Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Timolol-maintenance treatment

B M Calissendorff, N Marén

    Acta Ophthalmologica
    |December 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Timolol eyedrops effectively lower eye pressure long-term for glaucoma patients. Some patients, especially those with pseudoexfoliation, may require increased dosage or additional therapies over time.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tele-ophthalmology for the treatment in primary care of disorders in the anterior part of the eye.

    Journal of telemedicine and telecare·2001
    Same author

    Costs of medical and surgical treatment of glaucoma.

    Acta ophthalmologica Scandinavica·2001
    Same author

    Consumption of glaucoma medication.

    Acta ophthalmologica Scandinavica·2001
    Same author

    Blindness in glaucoma patients.

    Acta ophthalmologica Scandinavica·1998
    Same author

    Cataract development in adult bone marrow transplant recipients.

    Acta ophthalmologica Scandinavica·1995
    Same author

    Intraocular pressure after extracapsular cataract extraction with implantation of posterior chamber lenses.

    Acta ophthalmologica·1993
    Same journal

    Radial outer retina reflectivity (RORR) sign in LAMP2-associated retinopathy.

    Acta ophthalmologica·2026
    Same journal

    Deep learning in glaucoma referral: Performance assessment using a real-world setting.

    Acta ophthalmologica·2026
    Same journal

    Clinical manifestations of dual-gene variants in retinitis pigmentosa.

    Acta ophthalmologica·2026
    Same journal

    Genome-wide association and interaction analysis for proliferative retinopathy in adults with type 2 diabetes born during famine: The DOLCE study in Ukraine.

    Acta ophthalmologica·2026
    Same journal

    Dome-shaped macula in high myopia: Prevalence and clinical characteristics in a French cohort.

    Acta ophthalmologica·2026
    Same journal

    The role of pain in Graves' orbitopathy: Associations with clinical activity and quality of life.

    Acta ophthalmologica·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Pharmacology

    Background:

    • Ocular hypertension and glaucoma are leading causes of vision loss.
    • Topical timolol is a common first-line treatment for lowering intraocular pressure.
    • Long-term efficacy and potential adjustments in timolol therapy require further investigation.

    Purpose of the Study:

    • To evaluate the long-term hypotensive effect of topical timolol.
    • To assess the need for therapy adjustments in patients with ocular hypertension and glaucoma.
    • To identify factors influencing treatment response and ocular side effects.

    Main Methods:

    • Prospective study of 38 patients with ocular hypertension or glaucoma.
    • Treatment with topical timolol for 12-30 months (mean 20 months).
    • Monitoring of intraocular pressure and assessment of ocular side effects.

    Related Experiment Videos

    Main Results:

    • Topical timolol demonstrated a sustained hypotensive effect.
    • A need for increased therapy was observed, particularly in the glaucoma group.
    • Pseudoexfoliation cases often required initial concomitant therapy.
    • Ocular side effects were infrequent, including punctate keratitis and reduced corneal sensitivity.

    Conclusions:

    • Topical timolol provides a long-lasting reduction in intraocular pressure.
    • Treatment adjustments may be necessary for sustained efficacy, especially in glaucoma patients.
    • Pseudoexfoliation syndrome may necessitate earlier combination therapy.
    • Timolol is generally well-tolerated, with rare ocular side effects.